Katherine Griem to Combined Modality Therapy
This is a "connection" page, showing publications Katherine Griem has written about Combined Modality Therapy.
Connection Strength
0.342
-
Helical tomotherapy delivery of an IMRT boost in lieu of interstitial brachytherapy in the setting of gynecologic malignancy: feasibility and dosimetric comparison. Med Dosim. 2011; 36(2):206-12.
Score: 0.081
-
Variation in post-surgical lumpectomy cavity volume with delay in initiation of breast irradiation because of chemotherapy. Int J Radiat Oncol Biol Phys. 2010 Jul 01; 77(3):831-5.
Score: 0.077
-
Radiation recall reaction with docetaxel administration after accelerated partial breast irradiation with electronic brachytherapy. Brachytherapy. 2009 Jul-Sep; 8(3):331-4.
Score: 0.075
-
Continued malignant cell proliferation in head and neck tumors during cytotoxic therapy. Clin Cancer Res. 1996 Sep; 2(9):1453-60.
Score: 0.031
-
Radiation therapy in the management of rectal cancer. Hematol Oncol Clin North Am. 1989 Mar; 3(1):103-14.
Score: 0.019
-
The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol. 1987 Oct; 5(10):1546-55.
Score: 0.017
-
Concomitant cisplatin/5-FU infusion and radiotherapy in advanced head and neck cancer: 8-year analysis of results. Head Neck. 1997 Dec; 19(8):684-91.
Score: 0.009
-
Integration of surgery in multimodality therapy for esophageal cancer. Am J Clin Oncol. 1997 Feb; 20(1):11-5.
Score: 0.008
-
The dilemma of delayed cellulitis after breast conservation therapy. Arch Surg. 1996 Jun; 131(6):651-4.
Score: 0.008
-
Should multicentric disease be an absolute contraindication to the use of breast-conserving therapy? Int J Radiat Oncol Biol Phys. 1994 Aug 30; 30(1):49-53.
Score: 0.007
-
Primary radiation therapy to T1 and T2 breast cancer following conservative surgery. Which patients should be boosted? Am J Clin Oncol. 1994 Feb; 17(1):60-3.
Score: 0.007
-
Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer. J Clin Oncol. 1989 Jul; 7(7):846-56.
Score: 0.005